KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for Exact Sciences (EXAS) over the last 6 years, with Q3 2025 value amounting to $543000.0.

  • Exact Sciences' Asset Writedowns and Impairment fell 9709.59% to $543000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $845.0 million, marking a year-over-year increase of 259989.14%. This contributed to the annual value of $869.5 million for FY2024, which is 13990966.18% up from last year.
  • Latest data reveals that Exact Sciences reported Asset Writedowns and Impairment of $543000.0 as of Q3 2025, which was down 9709.59% from $6.3 million recorded in Q1 2025.
  • In the past 5 years, Exact Sciences' Asset Writedowns and Impairment ranged from a high of $838.2 million in Q4 2024 and a low of $69000.0 during Q1 2023
  • In the last 5 years, Exact Sciences' Asset Writedowns and Impairment had a median value of $6.1 million in 2022 and averaged $76.1 million.
  • Per our database at Business Quant, Exact Sciences' Asset Writedowns and Impairment surged by 634347.83% in 2024 and then crashed by 9709.59% in 2025.
  • Over the past 5 years, Exact Sciences' Asset Writedowns and Impairment (Quarter) stood at $20.2 million in 2021, then plummeted by 83.02% to $3.4 million in 2022, then crashed by 83.92% to $552000.0 in 2023, then skyrocketed by 151741.3% to $838.2 million in 2024, then tumbled by 99.94% to $543000.0 in 2025.
  • Its Asset Writedowns and Impairment was $543000.0 in Q3 2025, compared to $6.3 million in Q1 2025 and $838.2 million in Q4 2024.